(±)-Myrtenol [515-00-4]
Référence NB-64-129968-1g
Conditionnement : 1g
Marque : Neo Biotech
(±)-Myrtenol
Catalog No. TN8431 Copy Product Info
Purity: 98.74%
(±)-Myrtenol is the specific enantiomeric form of the bicyclic monoterpene alcohol known as Myrtenol. (-)-Myrtenol has been demonstrated to possess significant anti-anxiety effects in preclinical behavioral models; additionally, (-)-Myrtenol exhibits characteristics of gastric cell protection, suggesting potential therapeutic applications for gastrointestinal conditions.
(±)-Myrtenol
Copy Product Info(±)-Myrtenol is the specific enantiomeric form of the bicyclic monoterpene alcohol known as Myrtenol. (-)-Myrtenol has been demonstrated to possess significant anti-anxiety effects in preclinical behavioral models; additionally, (-)-Myrtenol exhibits characteristics of gastric cell protection, suggesting potential therapeutic applications for gastrointestinal conditions.
Cas No. 515-00-4
Select Batch
Purity:98.74%
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | (±)-Myrtenol is the specific enantiomeric form of the bicyclic monoterpene alcohol known as Myrtenol. (-)-Myrtenol has been demonstrated to possess significant anti-anxiety effects in preclinical behavioral models; additionally, (-)-Myrtenol exhibits characteristics of gastric cell protection, suggesting potential therapeutic applications for gastrointestinal conditions. |
| Molecular Weight | 152.23 |
| Formula | C10H16O |
| Cas No. | 515-00-4 |
| Smiles | OCC1=CCC2CC1C2(C)C |
| Storage | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 160 mg/mL (1051.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (32.85 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||